A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis
Clinical trial NCT04088409 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04088409
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-16
- Primary completion
- 2023-07-17
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.